ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer. Li J, Zheng C, Wang M, Umano AD, et al. Oncogene 2022 Jan 18. pii: 10.1038/s41388-021-02149.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li J, Zheng C, Wang M, Umano AD, et al. ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer. Oncogene 2022 Jan 18. pii: 10.1038/s41388-021-02149.
PMID: 35039634